the Board of Directors appointed Stephen A. Vintz, the Company’s Chief Financial Officer, and Mark Thurmond, the Company’s Chief Operating Officer, to serve as Co-Chief Executive Officers
The board of directors (the "Board) of Inseego Corp. ("Inseego" or the "Company") has appointed Juho Sarvikas as Chief Executive Officer of the Company, effective January 6, 2025.
the Board of Directors of Hills Bancorporation (the “Company”), appointed Lisa Shileny as President and CEO of the Company and Hills Bank and Trust Company (“Hills Bank”), on October 8, 2024, to be effective January 1, 2025.
On January 3, 2025, Dian C. Taylor, Chief Executive Officer, President and Chair of the Board of Directors ("Board") of Artesian Resources Corporation (the "Company"), began a paid leave from her positions as Chief Executive Officer and President.
Appointed
(interim)
Nicholle R. Taylor
Interim Chief Executive Officer, President and principal executive officer
Effective as of January 3, 2025, the Company’s Board of Directors appointed Nicholle R. Taylor to serve as the Company’s interim Chief Executive Officer, President and principal executive officer until Dian C. Taylor’s leave ends.
On January 2, 2025, Janet Carr submitted her resignation as Chief Executive Officer, principal financial officer and a member of the Board of Directors of Tandy Leather Factory, Inc. (the “Company”), effective as of the close of business on January 3, 2025.
On January 2, 2025, the Company’s Board of Directors appointed Johan Hedberg as the Company’s new Chief Executive Officer and a member of its Board of Directors, effective as of January 6, 2025.
Appointed
(interim)
Vassiliki "Celia" Economides
interim Chief Executive Officer and Chief Financial Officer
Gritstone bio, Inc.
Effective
2024-12-31
Filed
January 3, 2025, 6:59 PM ET
Also effective December 31, 2024 and following the closing of the Asset Sale, Vassiliki “Celia” Economides became interim Chief Executive Officer of the Company as well as Chief Financial Officer of the Company.
Departed
Andrew Allen
President and Chief Executive Officer
Gritstone bio, Inc.
Effective
2024-12-31
Successor
Vassiliki "Celia" Economides
Filed
January 3, 2025, 6:59 PM ET
Andrew Allen, M.D., Ph.D., President and Chief Executive Officer
Departed
Tania Secor
Chief Financial Officer
INTEGRAL AD SCIENCE HOLDING CORP.
Effective
2025-01-03
Successor
Jill Putman
Filed
January 3, 2025, 6:59 PM ET
Ms. Putman will replace Tania Secor, who departed as the Company's Chief Financial Officer as of the Effective Date to pursue new opportunities.
Appointed
(interim)
Jill Putman
Interim Chief Financial Officer
INTEGRAL AD SCIENCE HOLDING CORP.
Effective
2025-01-03
Filed
January 3, 2025, 6:59 PM ET
On January 3, 2025, Integral Ad Science Holding Corp. (the “Company”) announced the appointment of Jill Putman, a member of the Company’s Board of Directors (the “Board”), as non-employee Interim Chief Financial Officer, effective January 3, 2025 (“Effective Date”).
Jonathan Newton, previously Co-Chief Financial Officer and Treasurer of the Company, continues as the company’s sole Chief Financial Officer and Treasurer and was also appointed as the Secretary of the Company.
Effective January 1, 2025, Michael Beecher, previously Co-Chief Financial Officer and Secretary, ceased serving in those roles but will continue to be employed by the Company as a financial advisor.
On January 3, 2025, the Board of Directors (the “Board”) of Inno Holdings Inc. (the “Company”) received and accepted the resignation of Tianwei Li from his position as Chief Financial Officer of the Company.
On September 4, 2024, the Company announced that, effective January 1, 2025, Michael Katz will succeed Don Templin as the Company’s Executive Vice President and Chief Financial Officer.
On January 2, 2025, Tutor Perini Corporation (the “Company”) announced that its Board of Directors (the “Board”) has appointed Gary G. Smalley, the Company’s current President, to the position of Chief Executive Officer (“CEO”), effective January 1, 2025.
On January 1, 2025, the Company’s Board of Directors appointed David K. Traverse, the Company’s Chief Financial Officer, to serve as the Company’s interim Chief Executive Officer and President.
Effective as of January 2, 2025, Scott M. Coiante was appointed as our senior vice president and chief financial officer, in which capacity he will function as our principal financial officer.
Appointed
Travis Coy
Executive Vice President, Chief Financial Officer and Head of Corporate Development
On December 31, 2024, Immunocore LLC, an indirect, wholly owned subsidiary of Immunocore Holdings plc (“Parent” and, together with Immunocore LLC, the “Company”), entered into an employment agreement (the “Employment Agreement”) with Travis Coy, pursuant to which Mr. Coy will serve as the Company’s Executive Vice President, Chief Financial Officer and Head of Corporate Development as well as the Company’s principal financial officer, effective as of January 1, 2025 (the “Effective Date”).
Mr. McHugh, age 40, was appointed Co-President & Chief Financial Officer after previously serving as Executive Vice President – Chief Financial Officer.
Additionally, Dr. Poma resigned from his roles as Chief Executive Officer, Chief Scientific Officer, Treasurer and Interim Chief Financial Officer of the Company effective as of 11:59 pm EST on December 31, 2024.
Appointed
Craig Jalbert
sole director, President, Chief Executive Officer, Treasurer and Chief Financial Officer
Molecular Templates, Inc.
Effective
2025-01-01
Filed
January 2, 2025, 6:59 PM ET
Effective as of 12:00 am EST on January 1, 2025, the Board appointed Craig Jalbert, age 63, as sole director, President, Chief Executive Officer, Treasurer and Chief Financial Officer of the Company
On December 27, 2024, Haggai Ravid notified Currenc Group Inc., a Cayman Islands exempted company (the “Company”) of his resignation as the Company’s Chief Financial Officer, effective December 31, 2024
The Company’s CEO, Mr. Ronnie Ka Wah Hui, will serve as the Company’s Chief Financial Officer on an interim basis until the Company has found a replacement for Mr. Ravid.
On January 2, 2025, Caribou Biosciences, Inc., a Delaware corporation (the “Company”), announced the appointment of Sriram Ryali, age 44, to the position of Chief Financial Officer (“CFO”) of the Company, effective as of January 2, 2025 (the “Start Date”).
On November 25, 2024, Anuradha B. Subramanian, Chief Financial Officer of Bumble Inc. (the “Company”), notified the Company of her decision to resign to pursue other opportunities, effective as of March 14, 2025 (the “Effective Date”).
Following Mr. Field’s resignation, JoeBen Bevirt, the Company’s Chief Executive Officer, will serve as its acting principal financial officer, and Sergei Novikov, the Company’s Controller, will serve as its acting principal accounting officer and treasurer, in each case, effective December 13, 2024.
On December 1, 2024, Matthew Field, Chief Financial Officer of Joby Aviation, Inc. (the “Company”), notified the Company that he would be resigning, effective December 13, 2024, for personal reasons.
On November 21, 2024, Shahraab Ahmad notified Abpro Holdings, Inc., a Delaware corporation (the “Company”) of his resignation as the Company’s Chief Financial Officer, effective November 22, 2024.
Role change
Benjamin L. Schmitt
Executive Vice President, Chief Financial Officer and Treasurer
promoted Benjamin L. Schmitt from Senior Vice President, Chief Financial Officer and Treasurer of the Bancorp and the Bank to Executive Vice President, Chief Financial Officer and Treasurer of the Bancorp and the Bank.
On November 27, 2024, WW International, Inc. (the “Company”) announced that it had mutually agreed with Heather Stark, Chief Financial Officer of the Company, that she would cease serving as the Company’s Chief Financial Officer, effective December 27, 2024
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.